The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices – Includes Caremark, Express Scripts, ...

Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

One complicating factor is manufacturer rebates, which are discounts on prescription list prices provided by drug manufacturers to pharmacy benefit managers, which in turn may share some or all of ...

The Dean of the Faculty of Renewable Natural Resources, University of Ibadan, Professor Adejoke Akinyele, has called on the federal government to eliminate the activities of middlemen in the food ...

The Food and Drug Administration (FDA) has begun an expert, independent review of recent research on the health effects caused by heavy metals in tampons after lawmakers sounded the alarm on ...

Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in 2019, before the COVID-19 pandemic upended factory inspections in the U ...

The U.S. Drug Enforcement Administration (DEA) has allowed an increase in Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The DEA greenlighted the spike in ...

The trial results come less than two months after the U.S. Food and Drug Administration rejected Novo Nordisk's application for approval of a once-weekly basal insulin for diabetes patients.

the drug companies claim that they ultimately have to raise list prices in order to pay the middlemen.

The overall safety of insulin efsitora was similar to that of daily basal insulin therapies. Topline data were announced from 2 studies in the QWINT phase 3 clinical development program ...